Default company panoramic image
Ab924228 ce35 4fb6 bc54 afa4b18ae50f


Adipologix is developing a revolutionary soft tissue regeneration technology for the multi-billion dollar cosmetic & reconstructive plastic surgery markets.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Kingston, ON, Canada
  • Currency USD
  • Founded December 2013
  • Employees 2

Company Summary

Adipologix is developing regenerative medicine solutions for reconstructive & cosmetic plastic surgery procedures. The company’s patented decellularized adipose tissue technology is an innovative biomaterial that promotes the natural regeneration of the patient’s own tissues and provides plastic surgeons with an easy and cost-effective option for repairing or augmenting soft tissues of the face, breast, and body naturally and permanently.


  • 9d091b9b cd93 4686 b918 796af9a70e58

    Mr. Hendry has over a decade of experience in technology development & commercialization including the successful commercialization of a bone biomaterial technology platform. Mr. Hendry has a Masters degree in biomaterials from the University of Toronto and has managed all aspects of the product development cycle including product & process development, manufacturing scale-up, regulatory affairs, clinical evaluation, and product launch.

  • Abb8034c 4459 4a5a af4e 7a650e157c29
    Vice President

    Dr. Lauren Flynn is an Associate Professor at the University of Western Ontario and inventor of Adipologix's soft tissue regeneration technology. She has a Ph.D. in chemical engineering from the Institute of Biomaterials & Biomedical Engineering (University of Toronto) and her current research is focused on the development of new cell-based regenerative approaches with adipose-derived stem cells (ASCs) and naturally-derived bioscaffolds.